stella
beta
To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease — Stella
Home
/
Nonalcoholic Fatty Liver Disease
/
View on ClinicalTrials.gov
Recruiting
Back to Nonalcoholic Fatty Liver Disease trials
Trial locations
(1 site)
China
Tongji hospital, Wuhan, Hubei